Literature DB >> 21686490

Sudden appearance and spontaneous regression of diffuse large B cell lymphoma in a man with a broken arm.

Peter A Engel1, Ching Lee.   

Abstract

An elderly, demented man with stable κ bi-clonal gammopathy of unknown significance suffered a severe displaced right humeral fracture in a fall. One week later a rapidly enlarging head, neck and axillary adenopathy first appeared, including a 2 cm tonsillar node that partially obstructed the oropharynx. A left cervical node biopsy demonstrated diffuse large B cell lymphoma with CD20+, bcl-2+, κ+, CD3-, Epstein-Barr virus negative malignant cells. During the next month lymphadenopathy regressed more than 90% in the absence of treatment with chemotherapeutic agents, radiation or glucocorticoids. Following 2 months of clinical improvement, he died of pneumonia 95 days after the injury. An autopsy demonstrated residual right hilar and mediastinal malignant lymphadenopathy. These unusual events may be related to immunosuppressive and other systemic effects of acute injury on tumour behaviour.

Entities:  

Year:  2009        PMID: 21686490      PMCID: PMC3028429          DOI: 10.1136/bcr.10.2008.1036

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  32 in total

Review 1.  Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach.

Authors:  Jeremy S Abramson; Margaret A Shipp
Journal:  Blood       Date:  2005-04-26       Impact factor: 22.113

2.  Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.

Authors:  S M Ansell; M Stenson; T M Habermann; D F Jelinek; T E Witzig
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

3.  Spontaneous regression of malignant lymphoma of the lumbar spine.

Authors:  Shie Ohgi; Shigeru Ehara; Takashi Satoh; Sadafumi Kato; Kenji Shimosegawa; Yoji Ishida
Journal:  Skeletal Radiol       Date:  2001-12-04       Impact factor: 2.199

4.  Spontaneous remission in diffuse large cell lymphoma.

Authors:  J L Grem; G R Hafez; J H Brandenburg; P P Carbone
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

5.  Spontaneous regression in B cell, diffuse large cell type non-Hodgkin's lymphoma.

Authors:  J Tamura; T Jinbo; H Take; T Matsushima; M Sawamura; H Murukami; K Kubota; T Naruse; J Tsuchiya
Journal:  Acta Haematol       Date:  1993       Impact factor: 2.195

6.  Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2/SOCS3 recruitment sites revisited.

Authors:  K Friederichs; J Schmitz; M Weissenbach; P C Heinrich; F Schaper
Journal:  Eur J Biochem       Date:  2001-12

7.  Spontaneous remission of Epstein-Barr virus-negative non-Hodgkin's lymphoma after withdrawal of cyclosporine in a patient with refractory anemia.

Authors:  Masao Ogata; Hiroshi Kikuchi; Keiji Ono; Eiichi Ohtsuka; Ayako Gamachi; Kenji Kashima; Masaru Nasu
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

Review 8.  Malignant lymphoma of the scalp at the site of a previous blunt trauma: report of two cases.

Authors:  T Morioka; T Tashima; S Nishio; E Nishie; M Fukui; T Okamura
Journal:  Surg Neurol       Date:  1994-08

Review 9.  Surgical trauma: hyperinflammation versus immunosuppression?

Authors:  Michael D Menger; Brigitte Vollmar
Journal:  Langenbecks Arch Surg       Date:  2004-05-28       Impact factor: 3.445

Review 10.  Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.

Authors:  Mohit Trikha; Robert Corringham; Bernard Klein; Jean-François Rossi
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

View more
  2 in total

1.  Modelling lymphoma therapy and outcome.

Authors:  Katja Roesch; Dirk Hasenclever; Markus Scholz
Journal:  Bull Math Biol       Date:  2013-12-14       Impact factor: 1.758

2.  Spontaneous remission in diffuse large cell lymphoma: a case report.

Authors:  J Snijder; N Mihyawi; A Frolov; A Ewton; G Rivero
Journal:  J Med Case Rep       Date:  2019-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.